SIE Share Price

Open 0.07 Change Price %
High 0.07 1 Day 0.01 16.67
Low 0.07 1 Week 0.00 0.00
Close 0.07 1 Month 0.00 0.00
Volume 2693 1 Year 0.06 600.00
52 Week High 0.07
52 Week Low 0.01
SIE Important Levels
Resistance 2 0.07
Resistance 1 0.07
Pivot 0.07
Support 1 0.07
Support 2 0.07
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
LYC 0.12 9.09%
DJS 3.99 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
QSS 0.02 100.00%
AZZ 0.50 78.57%
AZZ 0.50 78.57%
QRX 0.03 50.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
CDT 0.01 -50.00%
RFT 0.01 -50.00%
NMI 0.01 -50.00%
NMI 0.01 -50.00%
More..

SciGen Ltd (ASX: SIE)

SIE Technical Analysis 5
As on 21st Jun 2017 SIE Share Price closed @ 0.07 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.03 & Strong Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
SIE Target for July
1st Target up-side 0.08
2nd Target up-side 0.09
3rd Target up-side 0.1
1st Target down-side 0.06
2nd Target down-side 0.05
3rd Target down-side 0.04
SIE Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.scigenltd.com
SIE Address
SIE
Gateway East
Suite 26-06/08
Singapore, 189721
Singapore
Phone: 65 6779 6638
Fax: 65 6779 3784
SIE Latest News
Control of hepatitis B virus infection in hematopoietic stem cell recipients ...   Nature.com   - 26th Oct 15
Pre-Filled Syringes Market Forecast 2015-2025   PR Newswire (press release)   - 12th Mar 15
Phillip Frost seeks SciGen reverse merger   Globes   - 09th Nov 14
Sagalio Energy Ltd among ASX % Gainers intra-day   Proactive Investors Australia   - 23rd Jul 14
SciGen bags $7M for interest in insulin manufacturing facility   Proactive Investors Australia   - 06th May 14
How computer-generated fake papers are flooding academia   The Guardian   - 27th Feb 14
Publishers withdraw more than 120 gibberish papers   Nature.com   - 25th Feb 14
Dart Energy Limited (ASX:DTE) Executive And Management Team In-Place To ...   ABN Newswire (press release)   - 13th Oct 10
CRAP paper accepted by journal   New Scientist   - 11th Jun 09
Sci B Vac Proven to Prevent Recurrence of Hepatitis B   FDA news (subscription)   - 12th Jun 07
Interactive Technical Analysis Chart SciGen Ltd ( SIE ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on SciGen Ltd
SIE Business Profile
SciGen Ltd, an integrated biotechnology company, develops, manufactures, markets, and distributes recombinant human health care biotechnology derived products. It focuses in the areas of gastroenterology, endocrinology, and immunology. The company’s principal products include SciTropin A, a recombinant human growth hormone; SciLin, a recombinant human insulin expressed in E. coli for treating diabetes; and SciLocyte, a recombinant granulocyte colony stimulating factor, which is used to prevent and treat the decrease of white blood cells resulting from chemotherapy. It also in-licenses and distributes pharmaceutical products and medical devices. SciGen Ltd operates in Singapore, Australia, India, Korea, Thailand, the Philippines, China, Indonesia, Pakistan, Vietnam, Hong Kong, and Malaysia. The company is headquartered in Singapore. SciGen Ltd is a subsidiary of Bioton S.A.